Kyle E. Rusthoven

3.5k total citations · 2 hit papers
31 papers, 2.7k citations indexed

About

Kyle E. Rusthoven is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Otorhinolaryngology. According to data from OpenAlex, Kyle E. Rusthoven has authored 31 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 13 papers in Surgery and 10 papers in Otorhinolaryngology. Recurrent topics in Kyle E. Rusthoven's work include Head and Neck Cancer Studies (10 papers), Advanced Radiotherapy Techniques (8 papers) and Salivary Gland Tumors Diagnosis and Treatment (7 papers). Kyle E. Rusthoven is often cited by papers focused on Head and Neck Cancer Studies (10 papers), Advanced Radiotherapy Techniques (8 papers) and Salivary Gland Tumors Diagnosis and Treatment (7 papers). Kyle E. Rusthoven collaborates with scholars based in United States. Kyle E. Rusthoven's co-authors include Brian D. Kavanagh, Changhu Chen, Madeleine Kane, Laurie E. Gaspar, Tracey E. Schefter, Thomas J. Pugh, Mark A. Chidel, Stuart H. Burri, Higinia R. Cárdenes and David Raben and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Kyle E. Rusthoven

31 papers receiving 2.6k citations

Hit Papers

Multi-Institutional Phase I/II Trial of Stereotactic Body... 2009 2026 2014 2020 2009 2009 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle E. Rusthoven United States 20 1.4k 1.1k 846 762 658 31 2.7k
Katsuyuki Karasawa Japan 26 2.8k 2.0× 1.8k 1.7× 744 0.9× 671 0.9× 1.2k 1.9× 144 4.0k
Yuzuru Niibe Japan 25 2.6k 1.8× 1.5k 1.4× 743 0.9× 620 0.8× 1.0k 1.5× 77 3.4k
Rosario Mazzola Italy 29 1.7k 1.2× 1.4k 1.2× 490 0.6× 408 0.5× 963 1.5× 137 2.7k
Signe Friesland Sweden 24 2.0k 1.4× 880 0.8× 705 0.8× 1.0k 1.3× 589 0.9× 71 2.9k
Dattatreyudu Nori United States 31 1.7k 1.2× 507 0.5× 921 1.1× 891 1.2× 422 0.6× 176 3.1k
Falk Roeder Germany 30 1.5k 1.0× 510 0.5× 992 1.2× 675 0.9× 403 0.6× 114 2.4k
Rafael Martínez‐Monge Spain 27 984 0.7× 578 0.5× 926 1.1× 919 1.2× 291 0.4× 128 2.3k
Florian Sterzing Germany 28 1.7k 1.2× 1.1k 1.0× 338 0.4× 494 0.6× 1.1k 1.7× 101 2.5k
Gian Carlo Mattiucci Italy 25 1.1k 0.8× 741 0.7× 659 0.8× 575 0.8× 688 1.0× 132 2.0k
Higinia R. Cárdenes United States 29 2.3k 1.6× 2.3k 2.1× 1.7k 2.0× 1.5k 2.0× 1.4k 2.1× 89 5.4k

Countries citing papers authored by Kyle E. Rusthoven

Since Specialization
Citations

This map shows the geographic impact of Kyle E. Rusthoven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle E. Rusthoven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle E. Rusthoven more than expected).

Fields of papers citing papers by Kyle E. Rusthoven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle E. Rusthoven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle E. Rusthoven. The network helps show where Kyle E. Rusthoven may publish in the future.

Co-authorship network of co-authors of Kyle E. Rusthoven

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle E. Rusthoven. A scholar is included among the top collaborators of Kyle E. Rusthoven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle E. Rusthoven. Kyle E. Rusthoven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petty, W. Jeffrey, James J. Urbanic, Tamjeed Ahmed, et al.. (2018). Long-Term Outcomes of a Phase 2 Trial of Chemotherapy With Consolidative Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 102(3). 527–535. 47 indexed citations
2.
Kounalakis, Nicole, Jennifer R. Diamond, Kyle E. Rusthoven, et al.. (2011). Diagnosis of invasive lobular carcinoma in a young woman presenting with pleomorphic lobular carcinoma in situ on core biopsy.. PubMed. 25(4). 351–6. 1 indexed citations
3.
Rusthoven, Kyle E., Steven J. Feigenberg, David Raben, et al.. (2010). Initial Results of a Phase I Dose-Escalation Trial of Concurrent and Maintenance Erlotinib and Reirradiation for Recurrent and New Primary Head-and-Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 78(4). 1020–1025. 21 indexed citations
4.
Rusthoven, Kyle E., Christine Olsen, Wilbur A. Franklin, et al.. (2010). Favorable Prognosis in Patients With High-Grade Glioma With Radiation Necrosis: The University of Colorado Reoperation Series. International Journal of Radiation Oncology*Biology*Physics. 81(1). 211–217. 34 indexed citations
5.
Chen, Changhu, Denise Damek, Laurie E. Gaspar, et al.. (2010). Phase I Trial of Hypofractionated Intensity-Modulated Radiotherapy With Temozolomide Chemotherapy for Patients With Newly Diagnosed Glioblastoma Multiforme. International Journal of Radiation Oncology*Biology*Physics. 81(4). 1066–1074. 44 indexed citations
6.
Pugh, Thomas J., Changhu Chen, Rachel Rabinovitch, et al.. (2010). Phase I Trial of Bortezomib and Concurrent External Beam Radiation in Patients With Advanced Solid Malignancies. International Journal of Radiation Oncology*Biology*Physics. 78(2). 521–526. 18 indexed citations
7.
Pugh, Thomas J., Ari Ballonoff, Kyle E. Rusthoven, et al.. (2009). Cardiac Mortality in Patients With Stage I and II Diffuse Large B-Cell Lymphoma Treated With and Without Radiation: A Surveillance, Epidemiology, and End-Results Analysis. International Journal of Radiation Oncology*Biology*Physics. 76(3). 845–849. 21 indexed citations
8.
Raben, Adam, et al.. (2009). Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy. Brachytherapy. 8(3). 297–303. 11 indexed citations
9.
McCammon, R.J., et al.. (2009). Toxicity Assessment of Pelvic Intensity-Modulated Radiotherapy With Hypofractionated Simultaneous Integrated Boost to Prostate for Intermediate- and High-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 75(2). 413–420. 51 indexed citations
10.
Rusthoven, Kyle E., et al.. (2009). Survival and Patterns of Relapse in Patients With Oral Tongue Cancer. Journal of Oral and Maxillofacial Surgery. 68(3). 584–589. 51 indexed citations
11.
Ballonoff, Ari, Kyle E. Rusthoven, Amanda Schwer, et al.. (2008). Outcomes and Effect of Radiotherapy in Patients With Stage I or II Diffuse Large B-Cell Lymphoma: A Surveillance, Epidemiology, and End Results Analysis. International Journal of Radiation Oncology*Biology*Physics. 72(5). 1465–1471. 33 indexed citations
12.
Rusthoven, Kyle E., David Raben, & Changhu Chen. (2008). Improved Survival in Patients With Stage III-IV Head and Neck Cancer Treated With Radiotherapy as Primary Local Treatment Modality. International Journal of Radiation Oncology*Biology*Physics. 72(2). 343–350. 12 indexed citations
13.
Schwer, Amanda, Ari Ballonoff, R.J. McCammon, et al.. (2008). Survival Effect of Neoadjuvant Radiotherapy Before Esophagectomy for Patients With Esophageal Cancer: A Surveillance, Epidemiology, and End-Results Study. International Journal of Radiation Oncology*Biology*Physics. 73(2). 449–455. 36 indexed citations
14.
Rusthoven, Kyle E., Thomas W. Flaig, David Raben, & Brian D. Kavanagh. (2008). High Incidence of Lung Cancer After Non–Muscle-Invasive Transitional Cell Carcinoma of the Bladder: Implications for Screening Trials. Clinical Lung Cancer. 9(2). 106–111. 13 indexed citations
15.
Rusthoven, Kyle E., et al.. (2008). Accelerated Partial-Breast Intensity-Modulated Radiotherapy Results in Improved Dose Distribution When Compared With Three-Dimensional Treatment-Planning Techniques. International Journal of Radiation Oncology*Biology*Physics. 70(1). 296–302. 51 indexed citations
16.
Ballonoff, Ari, David Raben, Kyle E. Rusthoven, et al.. (2008). Outcomes of Patients with N3 Neck Nodes Treated with Chemoradiation. The Laryngoscope. 118(6). 995–998. 26 indexed citations
17.
Rusthoven, Kyle E., Ari Ballonoff, David Raben, & Changhu Chen. (2007). Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma. Cancer. 112(2). 345–351. 157 indexed citations
18.
Rusthoven, Kyle E., Changhu Chen, David Raben, & Brian D. Kavanagh. (2007). Use of External Beam Radiotherapy Is Associated With Reduced Incidence of Second Primary Head and Neck Cancer: A SEER Database Analysis. International Journal of Radiation Oncology*Biology*Physics. 71(1). 192–198. 24 indexed citations
19.
Zhou, Wei, Michael Goodman, Robert H. Lyles, et al.. (2004). Surgical margin and gleason score as predictors of postoperative recurrence in prostate cancer with or without chromosome 8p allelic imbalance. The Prostate. 61(1). 81–91. 9 indexed citations
20.
Rusthoven, Kyle E., Mary Koshy, & Arnold C. Paulino. (2004). The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer. 101(11). 2641–2649. 231 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026